139 related articles for article (PubMed ID: 38186512)
1. A Race Against Time: Early-Onset Differentiation Syndrome Following All-Trans-Retinoic-Acid (ATRA) Therapy in Acute Promyelocytic Leukemia (AML-M3).
Ahmad K; Saleh M; Ali Y; Yaseen A; Ali M; Kakakhel M; Hayat MA
Cureus; 2023 Dec; 15(12):e50042. PubMed ID: 38186512
[TBL] [Abstract][Full Text] [Related]
2. Role of Prophylactic Steroids in Differentiation Syndrome.
Sultana J; Dutta J; Mustarin S; Dey P; Roy A; Mamoon MY
Cureus; 2022 Sep; 14(9):e29531. PubMed ID: 36312659
[TBL] [Abstract][Full Text] [Related]
3. Differentiation Syndrome, a Side Effect From the Therapy of Acute Promyelocytic Leukemia.
Reyhanoglu G; Hughes B; King KE; Cambridge R
Cureus; 2020 Dec; 12(12):e12042. PubMed ID: 33447473
[TBL] [Abstract][Full Text] [Related]
4. Distinct Characteristics of Sweet's Syndrome of the Scrotum Caused by All-
Imataki O; Yoshida S; Kaji T; Kida JI; Kubo H; Uemura M; Fujita H; Kadowaki N
Case Rep Oncol; 2021; 14(3):1466-1474. PubMed ID: 34899238
[TBL] [Abstract][Full Text] [Related]
5. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
Di Micco L; Mirenghi F; Morelli E; De Simone E
G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
[TBL] [Abstract][Full Text] [Related]
6. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
7. The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.
LaBella D; Regan S; Konig H; Egan DN; Bailey NA; Mawad R; Gilbert M; Pagel JM; Pu JJ
Front Oncol; 2022; 12():911745. PubMed ID: 35992790
[TBL] [Abstract][Full Text] [Related]
8. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
[TBL] [Abstract][Full Text] [Related]
9. Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy-A Management Challenge.
Droc G; Stancioaica MC; Soare CG; Stefan MG; Ingustu D; Martac C; Coriu D; Isac S; Suciu N; Andrei S
Life (Basel); 2023 May; 13(5):. PubMed ID: 37240786
[TBL] [Abstract][Full Text] [Related]
10. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal abnormality of acute promyelocytic leukemia other than
Imataki O; Uemura M
BMC Clin Pathol; 2016; 16():16. PubMed ID: 27708545
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion.
Kirkham JK; Liu YC; Foy SG; Ma J; Gheorghe G; Furtado LV; Popescu MI; Klco JM; Karol SE; Blackburn PR
Genes Chromosomes Cancer; 2023 Oct; 62(10):617-623. PubMed ID: 37283355
[TBL] [Abstract][Full Text] [Related]
13. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
Naeem M; Harrison K; Barton K; Nand S; Alkan S
Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
[TBL] [Abstract][Full Text] [Related]
14. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
Wang ZY; Chen Z; Huang W; Li XS; Lu JX; Huang LA; Zhang FQ; Gu LJ; Ouyang RR; Chen SJ
Blood Cells; 1993; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
[TBL] [Abstract][Full Text] [Related]
15. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.
Duprez E; Wagner K; Koch H; Tenen DG
EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of retinoic acid syndrome with high-dose dexamethasone pulse therapy in a child with acute promyelocytic leukemia treated with ATRA.
Asami K; Sasazaki Y; Utsumi J
Acta Paediatr Jpn; 1995 Jun; 37(3):384-7. PubMed ID: 7645395
[TBL] [Abstract][Full Text] [Related]
17. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
18. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
19. Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse.
Gupta V; Shariff M; Bajwa R; Patel I; Ayyad HA; Levitt MJ; Mencel PJ; Hossain MA
World J Oncol; 2019 Jun; 10(3):153-156. PubMed ID: 31312283
[TBL] [Abstract][Full Text] [Related]
20. An Acute Promyelocytic Leukemia Resistant to All-Trans Retinoic Acid: A Case Report of the
Castelijn DAR; Sijm G; Venniker-Punt B; Poddighe PJ; Wondergem MJ
Case Rep Oncol; 2023; 16(1):1443-1450. PubMed ID: 38028572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]